Malignant Large Intestinal Neoplasm — Trials

Malignant Large Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,500 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,622
Recruiting: 914
Ph III recruiting: 106
Growth YoY: +15.1%
Industry share: 22%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (742)

clinicaltrialsPublishedShowing 151–190 of 190 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04516681	Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer	recruiting	Phase 3	400	Fudan UniversityOTHER	1	Oct 24, 2024	clinicaltrials
NCT03635021	Study to Evaluate the Efficacy of FOLFOX + Panitumumab Followed by FOLFIRI + Bevacizumab (Sequence 1) Versus FOLFOX + Bevacizumab Followed by FOLFIRI + Panitumumab (Sequence 2) in Untreated Patients With Wild-type RAS Metastatic, Primary Left-sided, Unresectable Colorectal Cancer(CR-SEQUENCE)	active not recruiting	Phase 3	419	Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)